# Percutaneous Nephroscopic Treatment of Parapelvic Cysts

> **NCT05504512** · — · UNKNOWN · sponsor: **Xiangya Hospital of Central South University** · enrollment: 40 (estimated)

## Conditions studied

- Kidney Stone
- Parapelvic Cyst
- Kidney Diseases
- Recurrence

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT05504512
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-30
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05504512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05504512, "Percutaneous Nephroscopic Treatment of Parapelvic Cysts". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05504512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*